Information  X 
Enter a valid email address

E-Therapeutics PLC Ord 0.1P (ETX)

Date Time Source Announcement
17 May 2022 7:00 am
RNS
Notice of AGM and Posting of Annual Report
04 May 2022 7:00 am
RNS
Final results for the year ended 31 January 2022
27 Apr 2022 7:00 am
RNS
Notification of Full Year Results Date
12 Apr 2022 7:00 am
RNS
Key Milestone Achieved on Galapagos Collaboration
05 Apr 2022 7:00 am
RNS
Immuno-Oncology Research Collaboration with iTeos
16 Feb 2022 4:41 pm
RNS
Holding(s) in Company
15 Feb 2022 3:27 pm
RNS
Holding(s) in Company
31 Jan 2022 7:00 am
RNS
Total Voting Rights
20 Jan 2022 10:58 am
RNS
New Corporate Website
18 Jan 2022 4:41 pm
RNS
Holding(s) in Company
07 Jan 2022 7:00 am
RNS
Director Dealing and Issue of Equity
22 Nov 2021 7:00 am
RNS
Senior Management Update
26 Oct 2021 1:55 pm
RNS
Director Dealing
  7:01 am
RNS
Interim results for six months ended 31 July 2021
  7:00 am
RNS
RNAi Platform Characterisation Results
20 Oct 2021 7:00 am
RNS
Investor Presentation
11 Oct 2021 7:05 am
RNS
Patent Filing Applications
  7:00 am
RNS
Notice of Interim Results
24 Sep 2021 7:00 am
RNS
Commencement of trading on the OTCQX Best Market
02 Sep 2021 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
30 Jul 2021 7:00 am
RNS
Total Voting Rights
06 Jul 2021 7:00 am
RNS
Director Dealing and Issue of Equity
02 Jul 2021 7:00 am
RNS
Further milestone in Galapagos collaboration
30 Jun 2021 7:00 am
RNS
Total Voting Rights
21 Jun 2021 3:13 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Holding(s) in Company
18 Jun 2021 12:52 pm
RNS
Holding(s) in Company
17 Jun 2021 3:44 pm
RNS
Holding(s) in Company
16 Jun 2021 1:27 pm
RNS
Result of AGM
02 Jun 2021 7:00 am
RNS
Senior Management Appointment and Options Grant
21 May 2021 7:00 am
RNS
Notice of AGM and Posting of Annual Report
14 May 2021 7:00 am
RNS
Results of conditional Fundraise to raise �22.5m
13 May 2021 4:50 pm
RNS
Retail Offer
  4:45 pm
RNS
Proposed Fundraise in excess of �20 million
  7:00 am
RNS
Final Results for the Year Ended 31 January 2021
06 May 2021 7:00 am
RNS
Notification of Full Year Results Date
23 Apr 2021 7:00 am
RNS
ETX to receive two payments from Galapagos
29 Mar 2021 7:00 am
RNS
Appointment of Chief Financial Officer
01 Mar 2021 7:00 am
RNS
Change of Adviser
  7:00 am
RNS
Board Changes
25 Feb 2021 3:29 pm
RNS
Holding(s) in Company
16 Feb 2021 7:00 am
RNS
e-therapeutics to present at Shares Evening
10 Feb 2021 4:35 pm
RNS
Holding(s) in Company
01 Feb 2021 7:00 am
RNS
RNA Therapeutics Platform
28 Jan 2021 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
14 Jan 2021 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
12 Jan 2021 11:24 am
RNS
Holding(s) in Company
04 Jan 2021 4:31 pm
RNS
Director/PDMR Shareholding
18 Dec 2020 5:44 pm
RNS
Holding(s) in Company
16 Dec 2020 12:38 pm
RNS
Holding(s) in Company
08 Dec 2020 11:07 am
RNS
COVID-19 Project Update
21 Oct 2020 9:06 am
RNS
Issue of Equity
12 Oct 2020 3:15 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Appointment of Ali Mortazavi as CEO
  7:00 am
RNS
Interim Results for six months ended 31 July 2020
05 Oct 2020 12:07 pm
RNS
Notice of Interim Results

a d v e r t i s e m e n t